Using Biomarkers to Predict Cancer Risk
Author Information
Author(s): Li Xiaohong, Blount Patricia L., Vaughan Thomas L., Reid Brian J.
Primary Institution: University of Washington
Hypothesis
Can dynamic clonal evolution improve cancer risk prediction and early detection?
Conclusion
The study proposes a framework for using biomarkers in cancer risk management that accounts for the dynamic nature of cancer evolution.
Supporting Evidence
- Early detection of cancer can significantly reduce mortality.
- Current cancer screening models have limited success in reducing cancer mortality.
- No molecular biomarkers have yet been validated as robust predictors of cancer progression.
Takeaway
This study looks at how we can use special markers in our bodies to better predict and find cancer early, which can help save lives.
Methodology
The study defines cancer risk prediction and early detection using simple physical models and evaluates the implications of dynamic clonal evolution.
Potential Biases
The study acknowledges potential biases in biomarker research due to inadequate study designs and complexity of biospecimens.
Limitations
Current biomarkers are imperfect and do not meet the conditions for perfect cancer risk prediction.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website